246 related articles for article (PubMed ID: 15175120)
1. Salivary status in patients treated for head and neck cancer.
Dawes C; Odlum O
J Can Dent Assoc; 2004 Jun; 70(6):397-400. PubMed ID: 15175120
[TBL] [Abstract][Full Text] [Related]
2. Salivary flow rates measured during radiation therapy in head and neck cancer patients: a pilot study assessing salivary sediment formation.
Chambers MS; Tomsett KL; Artopoulou II; Garden AS; El-Naggar AK; Martin JW; Keene HJ
J Prosthet Dent; 2008 Aug; 100(2):142-6. PubMed ID: 18672129
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren's syndrome.
Rhodus NL; Bereuter J
J Otolaryngol; 2000 Feb; 29(1):28-34. PubMed ID: 10709169
[TBL] [Abstract][Full Text] [Related]
4. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?
Jellema AP; Doornaert P; Slotman BJ; Leemans CR; Langendijk JA
Radiother Oncol; 2005 Nov; 77(2):164-71. PubMed ID: 16256229
[TBL] [Abstract][Full Text] [Related]
5. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
Blanco AI; Chao KS; El Naqa I; Franklin GE; Zakarian K; Vicic M; Deasy JO
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1055-69. PubMed ID: 15990009
[TBL] [Abstract][Full Text] [Related]
6. How much saliva is enough for avoidance of xerostomia?
Dawes C
Caries Res; 2004; 38(3):236-40. PubMed ID: 15153694
[TBL] [Abstract][Full Text] [Related]
7. The effect of hyperbaric oxygenation on postradiation xerostomia and saliva in patients with head and neck tumours.
Cankar K; Finderle Z; Jan J
Caries Res; 2011; 45(2):136-41. PubMed ID: 21447949
[TBL] [Abstract][Full Text] [Related]
8. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report.
Jabbari S; Kim HM; Feng M; Lin A; Tsien C; Elshaikh M; Terrel JE; Murdoch-Kinch C; Eisbruch A
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):725-31. PubMed ID: 16199308
[TBL] [Abstract][Full Text] [Related]
9. Dramatic and prolonged decrease of whole salivary secretion in nasopharyngeal carcinoma patients treated with radiotherapy.
Jen YM; Lin YC; Wang YB; Wu DM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Mar; 101(3):322-7. PubMed ID: 16504865
[TBL] [Abstract][Full Text] [Related]
10. Salivary flow rate and clinical characteristics of patients with xerostomia according to its aetiology.
Cho MA; Ko JY; Kim YK; Kho HS
J Oral Rehabil; 2010 Mar; 37(3):185-93. PubMed ID: 20002531
[TBL] [Abstract][Full Text] [Related]
11. Does hyperbaric oxygen treatment have the potential to increase salivary flow rate and reduce xerostomia in previously irradiated head and neck cancer patients? A pilot study.
Forner L; Hyldegaard O; von Brockdorff AS; Specht L; Andersen E; Jansen EC; Hillerup S; Nauntofte B; Jensen SB
Oral Oncol; 2011 Jun; 47(6):546-51. PubMed ID: 21493124
[TBL] [Abstract][Full Text] [Related]
12. The role of submandibular salivary gland transfer in preventing xerostomia in the chemoradiotherapy patient.
Al-Qahtani K; Hier MP; Sultanum K; Black MJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jun; 101(6):753-6. PubMed ID: 16731395
[TBL] [Abstract][Full Text] [Related]
13. A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer.
Jham BC; Teixeira IV; Aboud CG; Carvalho AL; Coelho Mde M; Freire AR
Oral Oncol; 2007 Feb; 43(2):137-42. PubMed ID: 16798061
[TBL] [Abstract][Full Text] [Related]
14. Salivary levels of cortisol and chromogranin A in patients with dry mouth compared with age-matched controls.
Shigeyama C; Ansai T; Awano S; Soh I; Yoshida A; Hamasaki T; Kakinoki Y; Tominaga K; Takahashi T; Takehara T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Dec; 106(6):833-9. PubMed ID: 18755621
[TBL] [Abstract][Full Text] [Related]
15. The relative change in saliva secretion in relation to the exposed area of the salivary glands after radiotherapy of head and neck region.
Karlsson G
Swed Dent J; 1987; 11(5):189-94. PubMed ID: 3481134
[TBL] [Abstract][Full Text] [Related]
16. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
Rosenthal DI; Chambers MS; Weber RS; Eisbruch A
Semin Oncol; 2004 Dec; 31(6 Suppl 18):25-8. PubMed ID: 15726519
[TBL] [Abstract][Full Text] [Related]
17. Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer.
Thorstad WL; Chao KS; Haughey B
Semin Oncol; 2004 Dec; 31(6 Suppl 18):8-12. PubMed ID: 15726516
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of salivary gland function in lymphoma patients receiving head and neck irradiation.
Rodrigues NA; Killion L; Hickey G; Silver B; Martin C; Stevenson MA; Mauch PM; Ng AK
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1079-83. PubMed ID: 19327910
[TBL] [Abstract][Full Text] [Related]
19. Whole salivary flow rates following submandibular gland resection.
Jacob RF; Weber RS; King GE
Head Neck; 1996; 18(3):242-7. PubMed ID: 8860765
[TBL] [Abstract][Full Text] [Related]
20. Patients with head and neck cancer cured by radiation therapy: a survey of the dry mouth syndrome in long-term survivors.
Wijers OB; Levendag PC; Braaksma MM; Boonzaaijer M; Visch LL; Schmitz PI
Head Neck; 2002 Aug; 24(8):737-47. PubMed ID: 12203798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
